Hepatitis E

Revision as of 14:49, 18 August 2019 by ClaireLewis (talk | contribs) (Created page with "==Background== *Nonenveloped, RNA virus *Fecal-oral transmission ==Clinical Features== *Incubation period 2-10 weeks, usually 5-6 *Acute infection typically presents similar...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • Nonenveloped, RNA virus
  • Fecal-oral transmission


Clinical Features

  • Incubation period 2-10 weeks, usually 5-6
  • Acute infection typically presents similar to hepatitis A
  • Liver failure rare except in pregnant women
    • Pregnant women tend to have more severe disease, higher risk of fulminant hepatitis and liver failure, increased risk of fetal loss
    • Mortality of HEV infection in 3rd trimester: 20-25%[1]

Differential Diagnosis

Causes of acute hepatitis

Evaluation

  • Clinically indistinguishable from other viral hepatitides, no serologic test available[3]
  • LFTs
  • INR
    • Coagulopathy correlates w/more severe liver dysfunction
  • Acute hepatitis panel
    • Hep A Ab IgM
    • Hep B cAb IgM
    • Hep B sAg
    • Hep B sAb
    • Hep C Ab
Anti-hepatitis A, IgM Hepatitis B surface antigen Anti-hepatitis B core, IgM Anti-hepatitis C Interpretation
Positive Negative Negative Negative Acute hepatitis A
Negative Positive Positive Negative Acute hepatitis B
Negative Positive Negative Negative Chronic hepatitis B infection
Negative Negative Positive Negative Acute hepatitis B; quantity of hepatitis B surface antigen is too low to detect
Negative Negative Negative Positive Acute or chronic hepatitis C; additional tests are required to make the determination


Management

  • Supportive
    • Antiemetics
    • Oral or IV hydration
    • Avoid hepatotoxic medications
  • Patients with fulminant hepatic failure may be considered for liver transplant

Disposition

  • Typically discharge, admit if:
    • Pregnant
    • INR >2
    • Unable to tolerate PO
    • Intractable pain
    • Bilirubin >30
    • Hypoglycemia
    • Significant comorbidity/immunocompromised

See Also

External Links

References

  1. WHO fact sheet https://www.who.int/news-room/fact-sheets/detail/hepatitis-e
  2. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002 Dec 17; 137(12): 947-54.
  3. https://www.cdc.gov/hepatitis/hev/hevfaq.htm#c1